Lorence H. Kim, Director at Revolution Medicines, Inc. (RVMD), sold 17,090 shares at $206.60 ($3.6M) on 2026-09-08, disclosed to the SEC on 2026-09-10.
Scheduled sale ($3.6M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $206.60 | 706 | $146K | 4.1% |
| 2 | $207.33 | 999 | $207K | 5.8% |
| 3 | $208.55 | 3,587 | $748K | 20.9% |
| 4 | $209.56 | 2,853 | $598K | 16.7% |
| 5 | $210.50 | 4,730 | $996K | 27.8% |
| 6 | $211.36 | 3,844 |
| $812K |
| 22.7% |
| 7 | $212.27 | 371 | $79K | 2.2% |
| Total | $209.82 avg | 17,090 | $3.6M | 100% |
| Filing → |
| COWN | BUY | 2022-02-28 | $901K | — | Filing → |
| MRNA | SELL | 2020-06-04 | $14.1M | — | Filing → |
| MRNA | SELL | 2020-06-04 | $166K | — | Filing → |